Identifying Novel Cancer Therapeutic Targets : Science Webinar
On Wednesday, May 18, 2011, in a live, online educational seminar, “Identifying Novel Cancer Therapeutic Targets: Real-time, Label-free Cell Monitoring in RNAi Profiling.”
Date: Wednesday, May 18, 2011
Time: 12 noon Eastern, 9 a.m. Pacific, 4 p.m. GMT, 5 p.m. UK
Duration: 1 hour
Register now and submit your questions LIVE to the experts during the webinar!

For more information and complimentary registration visit:
www.sciencemag.org/webinar
Webinar Description
The identification of novel molecular targets for cancer can be a challenge. Such targets have recently been discovered in cell lines derived from aggressive childhood tumors using phenotypic profiling and RNAi screening. Further, studies have shown real-time, label-free cell monitoring using electrical impedance technology to be a viable technique to perform these assays and identify and validate novel cancer targets. Two current publications highlight the power of such an unbiased genetic screen to identify potential therapeutic targets from the protein kinome for Ewing’s sarcoma and neuroblastoma through the use of RNAi profiling combined with real-time, label-free technology. In this webinar, a panel of experts will discuss their research and describe the use of real-time, label-free cell monitoring in their investigation of novel cancer targets and the impact of their work on translational research and drug development.
During this Webinar our four distinguished panelists will:
* Discover how these scientists are incorporating real-time, label-free cell analysis in screening and validation to identify therapeutic targets
* Learn about the application of kinetic monitoring of cell growth
* Hear how label-free technology can be an enabling tool for cellular analysis
* Have the opportunity to ask questions of the experts live!
Register at:
www.sciencemag.org/webinar
Produced by the Science /AAAS Business Office and sponsored by Roche and xCELLigence.
Related Posts:
Share on Facebook
If you liked what you just read, you may want to subscribe to my
RSS FEED
Thanks for visiting!






Leave your response!